These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
144 related items for PubMed ID: 15657301
1. Enhanced Ca2+ response to AVP in preglomerular vessels from rats with genetic hypertension during different hydration states. Vagnes OB, Hansen FH, Feng JJ, Iversen BM, Arendshorst WJ. Am J Physiol Renal Physiol; 2005 Jun; 288(6):F1249-56. PubMed ID: 15657301 [Abstract] [Full Text] [Related]
2. Age-dependent regulation of vasopressin V1a receptors in preglomerular vessels from the spontaneously hypertensive rat. Vågnes B ØB, Hansen FH, Christiansen RE, Gjerstad C, Iversen BM. Am J Physiol Renal Physiol; 2004 May; 286(5):F997-1003. PubMed ID: 15075196 [Abstract] [Full Text] [Related]
3. Enhanced response to AVP in the interlobular artery from the spontaneously hypertensive rat. Hansen FH, Vågnes ØB, Iversen BM. Am J Physiol Renal Physiol; 2005 May; 288(5):F1023-31. PubMed ID: 15598845 [Abstract] [Full Text] [Related]
4. Upregulation of V(1) receptors in renal resistance vessels of rats developing genetic hypertension. Vågnes O, Feng JJ, Iversen BM, Arendshorst WJ. Am J Physiol Renal Physiol; 2000 Jun; 278(6):F940-8. PubMed ID: 10836981 [Abstract] [Full Text] [Related]
5. Renal hemodynamics in young and old spontaneously hypertensive rats during intrarenal infusion of arginine vasopressin. Christiansen RE, Roald AB, Gjerstad C, Tenstad O, Iversen BM. Kidney Blood Press Res; 2001 Jun; 24(3):176-84. PubMed ID: 11528210 [Abstract] [Full Text] [Related]
9. Cellular signaling and proliferative action of AVP in mesangium of SHR: effect of low density lipoprotein. Ishikawa S, Kusaka I, Higashiyama M, Nagasaka S, Saito T, Honda K, Saito T. Kidney Int; 1996 Nov; 50(5):1506-14. PubMed ID: 8914016 [Abstract] [Full Text] [Related]
10. Calcium signaling mechanisms in renal vascular responses to vasopressin in genetic hypertension. Feng JJ, Arendshorst WJ. Hypertension; 1997 Nov; 30(5):1223-31. PubMed ID: 9369280 [Abstract] [Full Text] [Related]
11. Angiotensin II-induced changes in G-protein expression and resistance of renal microvessels in young genetically hypertensive rats. Vyas SJ, Blaschak CM, Chinoy MR, Jackson EK. Mol Cell Biochem; 2000 Sep; 212(1-2):121-9. PubMed ID: 11108143 [Abstract] [Full Text] [Related]
12. Age-dependent regulation of renal vasopressin V(1A) and V₂ receptors in rats with genetic hypertension: implications for the treatment of hypertension. Burrell LM, Risvanis J, Dean RG, Patel SK, Velkoska E, Johnston CI. J Am Soc Hypertens; 2013 Sep; 7(1):3-13. PubMed ID: 23246465 [Abstract] [Full Text] [Related]
13. Alterations of renal vasopressin V1A and V2 receptors in spontaneously hypertensive rats. Tahara A, Tsukada J, Tomura Y, Wada K, Kusayama T, Ishii N, Yatsu T, Uchida W, Taniguchi N, Tanaka A. Pharmacology; 2003 Feb; 67(2):106-12. PubMed ID: 12566855 [Abstract] [Full Text] [Related]
14. P2Y2 receptor mRNA and protein expression is altered in inner medullas of hydrated and dehydrated rats: relevance to AVP-independent regulation of IMCD function. Kishore BK, Krane CM, Miller RL, Shi H, Zhang P, Hemmert A, Sun R, Nelson RD. Am J Physiol Renal Physiol; 2005 Jun; 288(6):F1164-72. PubMed ID: 15687250 [Abstract] [Full Text] [Related]
15. Pharmacological characterization of YM087, a potent, nonpeptide human vasopressin V1A and V2 receptor antagonist. Tahara A, Saito M, Sugimoto T, Tomura Y, Wada K, Kusayama T, Tsukada J, Ishii N, Yatsu T, Uchida W, Tanaka A. Naunyn Schmiedebergs Arch Pharmacol; 1998 Jan; 357(1):63-9. PubMed ID: 9459574 [Abstract] [Full Text] [Related]